Clinical trial Recruiting at 1 site Interventional Ages 18 to 40

Partial pulpotomy in mature lower molars with SIP using calcium hypochlorite vs sodium hypochlorite

Official title: Outcome of Partial Pulpotomy in Permanent Mandibular Molars With Symptomatic Irreversible Pulpitis After Wound Lavage With Calcium Hypochlorite or Sodium Hypochlorite

Run by Postgraduate Institute of Dental Sciences Rohtak · NCT07748676 · Data updated 2026-11-12

This trial tests whether washing the exposed pulp with calcium hypochlorite or with sodium hypochlorite during partial pulpotomy in adults helps healing and reduces pain.

More Symptomatic Irreversible Pulpitis (SIP) trials

Quick facts

Study typeInterventional
Ages18 Years to 40 Years
SexAll
Enrollment106 (estimated)
SponsorPostgraduate Institute of Dental Sciences Rohtak
Academic / other
Locations1 site (Rohtak, Haryana)
StatusRecruiting
StartedApril 29, 2026
Main results expectedOctober 28, 2027
Study endsOctober 28, 2027
Registry record updatedAugust 26, 2026
Trial IDNCT07748676 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–40 with mature permanent mandibular molars, extremely deep caries, SIP, and PAI score ≤ 2.

Probably not a fit

Patients with non-restorable teeth, necrotic pulp, sinus tract, swelling, or radiographic root resorption may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial compares two wound lavage solutions, 2.5% calcium hypochlorite and 2.5% sodium hypochlorite, used after removing a small portion of inflamed pulp in mature permanent mandibular molars with symptomatic irreversible pulpitis. Outcomes include clinical and radiographic success at 6 and 12 months, as well as patient-reported pain and oral health-related quality of life over time. Eligibility focuses on adults 18–40 with deeply carious, restorable molars and controlled inflammation. The study aims to determine which lavage agent better supports pulpal healing while preserving tooth structure. It is conducted at PGIDS Rohtak with a randomized allocation to the two intervention arms.

Why it matters

Potential benefit: If successful, one solution could become the preferred lavage agent to improve healing and patient experience after partial pulpotomy.

How similar studies have gone: Partial pulpotomy has shown promise in irreversible pulpitis, but direct comparisons of lavage agents are limited, making this approach relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. patients aged 18-40 years
2. Mature permanent mandibular molars with extremely deep caries (caries penetrating the entire thickness of the dentine radiographically, without radiopaque zone separating lesion from the pulp) and clinical diagnosis of SIP with PAI score ≤ 2
3. Periodontally healthy teeth (probing pocket depth ≤3 mm and mobility within normal limit)
4. Patients having physical status of class 1 or 2 according to ASA classification
5. Pulpal bleeding could be controlled within 10 min following pulp amputation

Exclusion Criteria:

1. Non restorable teeth
2. No pulp exposure even after complete caries excavation
3. Necrotic or partially necrotic pulp upon exposure
4. Presence of sinus tract or soft tissue swelling
5. Radiographic signs of internal or external root resorption
6. Pregnant women

Where it's running

  • Pgids
    Rohtak, Haryana, India
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.